Invus Financial Advisors, LLC
- SEC CIK
- 0001802978
- Latest filing
- Aug 14, 2024
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 8
- 0 vs. Q2 2021
- Portfolio value
- $373.3M
- −$128.6M (−25.6%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CPNGCoupang, Inc. | CL A | 4,264,571 | $118.8M | 31.8% | −300,000−6.6% | Reduced | History |
| TBLATaboola.com Ltd. | ORD SHS | 7,865,610 | $66.5M | 17.8% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,842,077 | $64.2M | 17.2% | 00.0% | Unchanged | History |
| NVCRNovoCure Ltd | ORD SHS | 350,884 | $40.8M | 10.9% | 00.0% | Unchanged | History |
| OYSTOyster Point Pharma, Inc. | COM | 2,768,586 | $32.8M | 8.8% | 00.0% | Unchanged | History |
| YEXTYext, Inc. | COM | 2,146,785 | $25.8M | 6.9% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,007,575 | $21.1M | 5.6% | 00.0% | Unchanged | History |
| UBXUnity Biotechnology, Inc. | COM | 1,094,998 | $3.29M | 0.9% | 00.0% | Unchanged | History |